HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoling Xu Selected Research

3-(2'-pyridyldithio)benzyldiazoacetate (MPDA)

11/2021Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics.
5/2021Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe3+ as a novel theranostic agent for T1/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer.
3/2021Sialic acid-engineered mesoporous polydopamine dual loaded with ferritin gene and SPIO for achieving endogenous and exogenous synergistic T2-weighted magnetic resonance imaging of HCC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoling Xu Research Topics

Disease

61Neoplasms (Cancer)
07/2022 - 08/2002
19Breast Neoplasms (Breast Cancer)
06/2022 - 11/2005
9Neoplasm Metastasis (Metastasis)
01/2022 - 08/2014
9Carcinogenesis
11/2021 - 08/2002
6Hepatocellular Carcinoma (Hepatoma)
01/2022 - 02/2004
5COVID-19
06/2021 - 01/2020
5Inflammation (Inflammations)
06/2021 - 01/2010
4Pulmonary Hypertension
07/2022 - 03/2016
4Infections
01/2022 - 01/2016
4Hypoxia (Hypoxemia)
01/2022 - 04/2016
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 01/2014
4Triple Negative Breast Neoplasms
10/2021 - 01/2017
4Genomic Instability
01/2019 - 10/2008
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 06/2014
3Hypertension (High Blood Pressure)
10/2019 - 09/2014
3Acute Lung Injury
01/2019 - 12/2018
3Craniosynostoses (Craniosynostosis)
12/2018 - 04/2008
3Acrocephalosyndactylia (Apert Syndrome)
12/2018 - 04/2008
3Lung Neoplasms (Lung Cancer)
01/2018 - 06/2004
3Hyperglycemia
09/2017 - 11/2011
3Insulin Resistance
09/2017 - 11/2010
2Aneuploidy (Aneuploid)
01/2022 - 10/2011
2Brain Neoplasms (Brain Tumor)
12/2021 - 01/2014
2Prostatic Neoplasms (Prostate Cancer)
11/2021 - 01/2017
2Acute Kidney Injury (Acute Renal Failure)
01/2021 - 01/2019
2Type 2 Diabetes Mellitus (MODY)
01/2020 - 09/2017
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2019 - 01/2018
2Pulmonary Embolism
04/2019 - 01/2015
2Esophageal Squamous Cell Carcinoma
03/2019 - 01/2015
2Hypersensitivity (Allergy)
01/2017 - 04/2010
2Urinary Bladder Neoplasms (Bladder Cancer)
12/2015 - 10/2011
2Hyperplasia
09/2006 - 11/2004
1Carcinoma (Carcinomatosis)
07/2022

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
03/2020 - 08/2002
9DNA (Deoxyribonucleic Acid)IBA
06/2022 - 06/2004
9Pharmaceutical PreparationsIBA
01/2022 - 06/2014
7Immune Checkpoint InhibitorsIBA
06/2022 - 01/2021
6Sirtuin 1IBA
10/2021 - 10/2008
6Cisplatin (Platino)FDA LinkGeneric
01/2021 - 08/2014
4Peptides (Polypeptides)IBA
05/2022 - 01/2019
4IronIBA
05/2022 - 01/2016
4VaccinesIBA
04/2022 - 10/2012
4tocilizumab (atlizumab)FDA Link
06/2021 - 01/2020
3Liposomes (Liposome)IBA
06/2022 - 01/2020
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
06/2022 - 01/2006
3Doxorubicin (Adriamycin)FDA LinkGeneric
05/2022 - 05/2021
3ferric oxide (iron oxide)IBA
05/2022 - 03/2021
3Ferritins (Ferritin)IBA
04/2022 - 01/2019
3CateninsIBA
01/2022 - 11/2017
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 10/2016
3Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 05/2015
33-(2'-pyridyldithio)benzyldiazoacetate (MPDA)IBA
11/2021 - 03/2021
31-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2021 - 07/2020
3AntibodiesIBA
10/2021 - 01/2018
3Biomarkers (Surrogate Marker)IBA
06/2021 - 01/2019
3Transforming Growth Factor beta (TGF-beta)IBA
01/2021 - 12/2003
3MicellesIBA
01/2021 - 07/2020
3Therapeutic UsesIBA
10/2020 - 08/2014
3Long Noncoding RNAIBA
01/2020 - 03/2016
3Biological ProductsIBA
01/2020 - 07/2007
3Interleukin-6 (Interleukin 6)IBA
01/2020 - 12/2005
3Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
12/2018 - 04/2008
3Insulin (Novolin)FDA Link
01/2013 - 11/2010
2apatinibIBA
07/2022 - 10/2019
2Contrast MediaIBA
05/2022 - 01/2019
2Single-Stranded DNA (DNA, Single Stranded)IBA
05/2022 - 04/2010
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2022 - 01/2020
2ErbB Receptors (EGF Receptor)IBA
12/2021 - 01/2014
2polydopamineIBA
11/2021 - 05/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 01/2021
2Adenosine (Adenocard)FDA LinkGeneric
10/2021 - 01/2021
2Anti-Bacterial Agents (Antibiotics)IBA
08/2021 - 11/2018
2E-SelectinIBA
05/2021 - 01/2021
2N-Acetylneuraminic Acid (Sialic Acid)IBA
05/2021 - 01/2019
2Cancer VaccinesIBA
05/2021 - 12/2015
2Histone Deacetylases (Histone Deacetylase)IBA
04/2020 - 10/2008
2Third Generation CephalosporinsIBA
01/2020 - 07/2012
2Blood Glucose (Blood Sugar)IBA
01/2020 - 11/2010
2baicalinIBA
11/2019 - 05/2015
2Purinergic P2X3 ReceptorsIBA
11/2019 - 05/2015
2Angiotensin-Converting Enzyme 2IBA
04/2019 - 01/2019
2MicroRNAs (MicroRNA)IBA
01/2019 - 01/2014
2PlatinumIBA
02/2017 - 12/2016
2GemcitabineFDA Link
07/2015 - 05/2015
21- (4- dimethylaminomethylphenyl)- 8,9- dihydro- 7H- 2,7,9a- benzo(cd)azulen- 6- oneIBA
06/2014 - 01/2006
2Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2014 - 02/2004
2Glucose (Dextrose)FDA LinkGeneric
11/2011 - 11/2010
2ResveratrolIBA
10/2008 - 10/2008
2CarcinogensIBA
07/2007 - 11/2004
2beta CateninIBA
07/2007 - 12/2003

Therapy/Procedure

30Therapeutics
07/2022 - 08/2006
10Drug Therapy (Chemotherapy)
01/2022 - 05/2015
7Immunotherapy
04/2022 - 10/2011
3Microspheres (Microsphere)
01/2022 - 01/2019
3Intravenous Injections
01/2022 - 01/2019
3Precision Medicine
11/2021 - 01/2021
3Photochemotherapy (Photodynamic Therapy)
10/2021 - 07/2020
2Radiotherapy
12/2021 - 11/2021
2Photothermal Therapy
11/2021 - 05/2021
2Aftercare (After-Treatment)
01/2020 - 11/2004